BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15654388)

  • 21. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
    Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
    J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells.
    Teraishi F; Guo W; Zhang L; Dong F; Davis JJ; Sasazuki T; Shirasawa S; Liu J; Fang B
    Cancer Res; 2006 Jun; 66(12):6072-9. PubMed ID: 16778179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Trypanosoma cruzi PIN1 gene encodes a parvulin peptidyl-prolyl cis/trans isomerase able to replace the essential ESS1 in Saccharomyces cerevisiae.
    Erben ED; Daum S; Téllez-Iñón MT
    Mol Biochem Parasitol; 2007 Jun; 153(2):186-93. PubMed ID: 17418434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors.
    Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T
    J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
    Wang F; Chen J; Liu X; Shen X; He X; Jiang H; Bai D
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):372-6. PubMed ID: 16508195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
    Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
    EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis.
    Davis MA; Chang SH; Trump BF
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):93-101. PubMed ID: 8917680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of levoglucosenone-derived ras activation inhibitors.
    Müller C; Gomez-Zurita Frau MA; Ballinari D; Colombo S; Bitto A; Martegani E; Airoldi C; van Neuren AS; Stein M; Weiser J; Battistini C; Peri F
    ChemMedChem; 2009 Apr; 4(4):524-8. PubMed ID: 19226500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-permeable bicyclic peptide inhibitors against intracellular proteins.
    Lian W; Jiang B; Qian Z; Pei D
    J Am Chem Soc; 2014 Jul; 136(28):9830-3. PubMed ID: 24972263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
    Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
    Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prolyl isomerase pin1 protecting against aging diseases].
    Uchida T; Fanghaenel J; Uchida C; Ostroff L
    Tanpakushitsu Kakusan Koso; 2005 Sep; 50(11):1413-9. PubMed ID: 16146189
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Im JY; Kim J; Choi WS; Kim HS
    Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of hPin1 WW N-terminal domain boundaries on function, protein stability, and folding.
    Jäger M; Nguyen H; Dendle M; Gruebele M; Kelly JW
    Protein Sci; 2007 Jul; 16(7):1495-501. PubMed ID: 17586778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors.
    Wildemann D; Hernandez Alvarez B; Stoller G; Zhou XZ; Lu KP; Erdmann F; Ferrari D; Fischer G
    Biol Chem; 2007 Oct; 388(10):1103-11. PubMed ID: 17937625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone.
    Hennig L; Christner C; Kipping M; Schelbert B; Rücknagel KP; Grabley S; Küllertz G; Fischer G
    Biochemistry; 1998 Apr; 37(17):5953-60. PubMed ID: 9558330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasite biology: PINning down Theileria.
    Attar N
    Nat Rev Microbiol; 2015 Mar; 13(3):126-7. PubMed ID: 25659319
    [No Abstract]   [Full Text] [Related]  

  • 39. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression.
    Li H; Wang S; Zhu T; Zhou J; Xu Q; Lu Y; Ma D
    Oncol Rep; 2006 Sep; 16(3):491-6. PubMed ID: 16865248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study Reveals Target of Leukemia Drug.
    Cancer Discov; 2015 Jul; 5(7):OF13. PubMed ID: 25968117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.